-- 
Archos, Bayer, Bureau Veritas, Merck: European Equity Preview

-- B y   V i c t o r i a   T a y l o r
-- 
2011-08-09T04:00:03Z

-- http://www.bloomberg.com/news/2011-08-08/archos-bayer-bureau-veritas-merck-european-equity-preview.html
The following companies’ shares may
have unusual moves in European trading. Stock symbols are in
parentheses.  The Stoxx Europe 600 Index fell 4.1 percent to 228.98. The
Stoxx 50 Index dropped 3.6 percent to 2,199.01. The Euro Stoxx
50 Index, a benchmark measure for nations using the euro,
decreased 3.7 percent to 2,286.91.  Archos (JXR)  SA: The maker of tablet computers posted a
first-half profit of 1.7 million euros ($2.4 million). The
shares fell 8.8 percent to 7.27 euros.  Bayer AG (BAYN)   and  Merck KGaA (MRK)  : German
pharmaceutical companies must grant more than 2 billion euros in
discounts on  prescription drugs  this year, Handelsblatt
reported, citing a study from research firm IMS Health. Bayer’s
shares dropped 4.1 percent to 46.73 euros, while Merck’s shares
lost 4.2 percent to 64.80 euros.  Bureau Veritas SA (BVI)  : The consulting-services
provider said it acquired Civil-Aid Technoclinic Pty, an Indian
provider of evaluation services for public and industrial
infrastructure. The shares fell 3.9 percent to 51.59 euros.  To contact the reporter on this story:
Victoria Taylor in New York at 
 vtaylor6@bloomberg.net   To contact the editor responsible for this story:
Michael P. Regan at 
 mregan12@bloomberg.net  